147 related articles for article (PubMed ID: 9742056)
1. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Kiss E; Brittsan AG; Edes I; Grupp IL; Grupp G; Kranias EG
Circ Res; 1998 Sep; 83(6):608-13. PubMed ID: 9742056
[TBL] [Abstract][Full Text] [Related]
2. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
Kiss E; Jakab G; Kranias EG; Edes I
Circ Res; 1994 Aug; 75(2):245-51. PubMed ID: 8033338
[TBL] [Abstract][Full Text] [Related]
4. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Chu G; Luo W; Slack JP; Tilgmann C; Sweet WE; Spindler M; Saupe KW; Boivin GP; Moravec CS; Matlib MA; Grupp IL; Ingwall JS; Kranias EG
Circ Res; 1996 Dec; 79(6):1064-76. PubMed ID: 8943945
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormones increase the contractility but suppress the effects of beta-adrenergic agonist by decreasing phospholamban expression in rat atria.
Kaasik A; Paju K; Vetter R; Seppet EK
Cardiovasc Res; 1997 Jul; 35(1):106-12. PubMed ID: 9302353
[TBL] [Abstract][Full Text] [Related]
7. The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in (Ca2+)-sensitivity or myosin ATPase-activity of the contractile proteins.
Schwinger RH; Brixius K; Savvidou-Zaroti P; Bölck B; Zobel C; Frank K; Kranias EG; Hoischen S; Erdmann E
Basic Res Cardiol; 2000 Feb; 95(1):12-8. PubMed ID: 10752541
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of the reduction by thyroid hormone of beta-adrenergic relaxation rate stimulation in rat heart.
Beekman RE; van Hardeveld C; Simonides WS
Biochem J; 1989 Apr; 259(1):229-36. PubMed ID: 2541682
[TBL] [Abstract][Full Text] [Related]
9. Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone.
Nagai R; Zarain-Herzberg A; Brandl CJ; Fujii J; Tada M; MacLennan DH; Alpert NR; Periasamy M
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2966-70. PubMed ID: 2523077
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca(2+)-cycling proteins in the baboon. Implications for the force-frequency and relaxation-frequency relationships.
Khoury SF; Hoit BD; Dave V; Pawloski-Dahm CM; Shao Y; Gabel M; Periasamy M; Walsh RA
Circ Res; 1996 Oct; 79(4):727-35. PubMed ID: 8831496
[TBL] [Abstract][Full Text] [Related]
11. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins.
Arai M; Otsu K; MacLennan DH; Alpert NR; Periasamy M
Circ Res; 1991 Aug; 69(2):266-76. PubMed ID: 1830516
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone downregulates the expression and function of sarcoplasmic reticulum-associated CaM kinase II in the rabbit heart.
Jiang M; Xu A; Narayanan N
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1384-94. PubMed ID: 16617128
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone regulation of calcium cycling proteins.
Carr AN; Kranias EG
Thyroid; 2002 Jun; 12(6):453-7. PubMed ID: 12165106
[TBL] [Abstract][Full Text] [Related]
14. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
15. Phospholamban ablation and compensatory responses in the mammalian heart.
Chu G; Ferguson DG; Edes I; Kiss E; Sato Y; Kranias EG
Ann N Y Acad Sci; 1998 Sep; 853():49-62. PubMed ID: 10603936
[TBL] [Abstract][Full Text] [Related]
16. Altered phospholamban-calcium ATPase interaction in cardiac sarcoplasmic reticulum during the progression of sepsis.
Wu LL; Tang C; Dong LW; Liu MS
Shock; 2002 May; 17(5):389-93. PubMed ID: 12022759
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone.
Seppet EK; Kolar F; Dixon IM; Hata T; Dhalla NS
Mol Cell Biochem; 1993 Dec; 129(2):145-59. PubMed ID: 8177237
[TBL] [Abstract][Full Text] [Related]
18. Phospholamban gene dosage effects in the mammalian heart.
Luo W; Wolska BM; Grupp IL; Harrer JM; Haghighi K; Ferguson DG; Slack JP; Grupp G; Doetschman T; Solaro RJ; Kranias EG
Circ Res; 1996 May; 78(5):839-47. PubMed ID: 8620604
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone modulates inotropic responses, alpha-adrenoceptor density and catecholamine concentrations in the rat heart.
Zwaveling J; Batink HD; de Jong J; Winkler Prins EA; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):755-64. PubMed ID: 8971736
[TBL] [Abstract][Full Text] [Related]
20. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
Koss KL; Grupp IL; Kranias EG
Basic Res Cardiol; 1997; 92 Suppl 1():17-24. PubMed ID: 9202840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
